Cadence Capital Management’s Veracyte VCYT Stock Holding History

Cadence Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-73,050	Closed	-$2.04M	–	472
2019 Q4	$2.04M	Sell	73,050 -45,543	-38%	-$1.18M	0.22%	130
2019 Q3	$2.85M	Buy	118,593 +2,294	+2%	+$61K	0.4%	67
2019 Q2	$3.32M	Sell	116,299 -3,884	-3%	-$97K	0.33%	63
2019 Q1	$3.01M	Buy	+120,183	New	+$2.3M	0.27%	94

Other funds holding VCYT

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cadence Capital Management's VCYT Position: Q1 2020 in Review

Cadence Capital Management sold out of Veracyte (VCYT) in Q1 2020, closing a stake of 73,050 shares — an estimated $2.04M sold.

Cadence Capital Management first reported a position in VCYT in Q1 2019 and held it in 4 quarters. The position peaked at $3.32M in Q2 2019. 165 funds tracked by Wall St. Rank hold VCYT as of Q1 2020.

Cadence Capital Management reported no remaining Veracyte position as of Q1 2020 after selling out during the quarter.
Cadence Capital Management sold 73,050 Veracyte shares in Q1 2020, an estimated $2.04M.
Cadence Capital Management first reported a position in Veracyte in Q1 2019 and held it in 4 quarters.
Cadence Capital Management's Veracyte position peaked at $3.32M in Q2 2019.
165 funds tracked by Wall St. Rank held Veracyte as of Q1 2020.

Based on Cadence Capital Management's 13F filing for Q1 2020, filed 4 May 2020.